SteatoticLiver.org › RESOURCES › Pharma & Diagnostic Portals › MASH & Liver Medication Portfolios
Pharma Portfolios
Industry Portfolios • Approved Therapies, Support Hubs & Late-Stage Pipelines

MASH & Liver Medication Portfolios

Complete index of unbranded education portals, FDA-approved MASH / HE / LAL-D therapy websites, patient support lines, and Phase 3 pipeline sponsor hubs.

✓ 27 Verified Live Resources1 SLF Guides/Tools • 26 External PortalsUpdated Nov 2026 • SLD Umbrella Nomenclature
Why We Built This Directory (Straight Talk)

Modern pharmaceutical portfolios often split into three separate websites per company: an unbranded disease site (like Madrigal's TakingOnFattyLiverAndMASH.com or Salix's UnderstandingHE.com), a branded medication portal (like Rezdiffra.com, mash.wegovy.com, or Kanuma.com), and a financial & insurance support hub (like Madrigal Patient Support, NovoCare, or Alexion OneSource). We map all three layers together below so you never miss a support service.

Clear FDA Status Separation: For MASH specifically, Rezdiffra (resmetirom) and Wegovy (semaglutide 2.4 mg) hold FDA indications for adults with noncirrhotic F2-F3 MASH. Other sponsors listed below (Eli Lilly, Boehringer Ingelheim, Akero, 89bio/Roche, Inventiva, Sagimet) are included for transparent clinical-trial and pipeline education — their liver indications are investigational unless noted otherwise. Xifaxan is FDA-approved for overt HE recurrence in cirrhosis; Kanuma is FDA-approved for rare monogenic LAL-D.

At-a-Glance Map of Major SLD Pharmaceutical Portfolios

CompanySLD Focus / FDA StatusUnbranded EducationBranded & Support Portals
Madrigal PharmaceuticalsF2-F3 MASH (FDA-approved Rezdiffra)TakingOnFattyLiverAndMASH.com (EN + ES + Specialist Finder)Rezdiffra.com (Real Voices™) • MadrigalPatientSupport.com (1-877-219-7770)
Novo NordiskF2-F3 MASH (FDA-approved Wegovy)TruthAboutWeight.commash.wegovy.com (Provider Finder) • NovoCare.com
Salix / Bausch HealthCirrhosis — Hepatic Encephalopathy (FDA-approved Xifaxan)UnderstandingHE.comXifaxan.com/he
Alexion / AstraZenecaRare Monogenic SLD — LAL-D (FDA-approved Kanuma)LALDSource.comKanuma.com • Alexion OneSource™
Eli Lilly & Boehringer IngelheimObesity/T2D & Phase 3 MASH / Cirrhosis PipelinesMetabolic & CRM trial educationtrials.lilly.com, LillyCares.com • MyStudyWindow.com
Akero, 89bio/Roche, Inventiva, SagimetPhase 3 MASH & F4 Cirrhosis Pipelines (FGF21, pan-PPAR, FASN)Mechanism & trial overviewsAkero • 89bio • Inventiva • Sagimet

Verified Live Resources (27)

Showing 27 of 27 verified resources
Source Type:
Language:

No resources matched that exact combination of filters.

Know a trusted patient resource we should add, or spotted a moved link? Steatotic Liver Foundation maintains this directory for the entire SLD community. Join our network or help keep patient navigation free for every family.